NVST · Envista Holdings Corp · Financials

$23.97 +0.78 (+3.36%)

S&P 400 member Russell 1000 member Rebalance outlook locked

Market Cap

$3.72B

160.62M

Volume · Oct 22 3.37M Avg daily vol (3M) 2.89M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →

Revenue

$2.72B +8.3%

FY2025

Net Income

$47M +104.2%

FY2025

Gross Margin

54.67% 0pp

FY2025

Operating Margin

7.95% +49.3pp

FY2025

Diluted EPS

$0.28 +104.3%

FY2025

Operating Cash Flow

$275.7M -18.1%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow Adjusted All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	+1.9%	+7.1%	—	—	$2.86B	$2.72B	$2.51B	$2.57B	$2.57B	$2.51B^G	$1.93B	$2.28B	$2.84B	$2.81B
Cost of Revenue	+4.1%	+7.1%	—	—	$1.28B	$1.23B	$1.14B	$1.13B	$1.09B	$1.08B	$874.3M	$935.6M	$1.24B	$1.19B
Gross Profit	+0.3%	+7.1%	—	—	$1.58B	$1.49B	$1.37B	$1.44B	$1.47B	$1.43B	$1.05B	$1.35B	$1.6B	$1.62B
Gross Margin	—	—	—	—	—	54.67%	54.68%	56.13%	57.41%	56.86%	54.68%	59.05%	56.31%	57.68%
Research & Development	+4.4%	+5.6%	—	—	$120.8M	$114M	$99.1M	$93.8M	$100.1M	$100.5M	$86.7M	$133.1M	$172M	$172.4M
Selling, General & Administrative	+3.1%	+4.6%	—	—	$1.18B	$1.16B	$1.16B	$1.06B	$1.06B	$1.02B	$924.6M	$980.4M	$1.13B	$1.06B
Amortization of Intangibles	-10.5%	-2.8%	—	—	—	$75.9M	$82.3M	$99.6M	$106M	$81.5M	$87.3M	$85.5M	$90.6M	$82M
Depreciation & Amortization	-5.6%	-1.0%	—	—	$115.3M	$116M	$123.1M	$135.6M	$137.8M	$117.8M	$121.7M	$120.4M	$130M	$121.4M
Restructuring Charges	—	—	—	—	—	$0	$0	$1.3M	$4.7M	$10.8M	$89.3M	$13M	$23.7M	$35.8M
Total Operating Expenses	—	—	—	—	—	—	$2.27B	$2.18B	$2.13B	—	—	—	—	—
Operating Income	-12.2%	+37.8%	—	—	$273.6M	$216.1M	-$1.04B	$31.5M	$319.2M	$306.2M	$43.5M	$235.7M	$298.4M	$386.6M
Operating Margin	—	—	—	—	—	7.95%	-41.35%	1.23%	12.42%	12.2%	2.25%	10.32%	10.49%	13.75%
EBITDA	-10.1%	+15.0%	—	—	$388.9M	$332.1M	-$915.1M	$167.1M	$457M	$424M	$165.2M	$356.1M	$428.4M	$508M
Interest Expense	—	—	—	—	—	—	—	$63.4M	$38.4M	$54.1M	$62.5M	$3.5M	$0	$0
Other Non-Operating Income	—	—	—	—	-$4.1M	-$2.3M	-$100K	-$23M	$3.1M	$2.4M	-$1M	$1.5M	$2.7M	—
Investment Income (Loss)	—	—	—	—	-$8.2M	-$6.2M	-$1.1M	$3.6M	$0	—	—	—	—	—
Pretax Income	-14.5%	—	—	—	$234.1M	$177.2M	-$1.08B	-$54.9M	$283.9M	$254.5M	-$20M	$233.7M	$301.1M	$386.7M
Income Tax	+41.6%	—	—	—	$139.1M	$130.2M	$33.9M	$45.3M	$45.9M	-$9M	-$62.5M	$49.6M	$70.4M	$85.6M
Net Income	-42.2%	+7.1%	—	—	$95M	$47M	-$1.12B	-$100.2M	$243.1M	$340.5M	$33.3M	$217.6M	$230.7M	$301.1M
Net Margin	—	—	—	—	—	1.73%	-44.56%	-3.9%	9.46%	13.57%	1.73%	9.52%	8.11%	10.71%
Comprehensive Income	+23.6%	+28.9%	—	—	$68.6M	$304.9M	-$1.27B	-$92.3M	$161.5M	$288.8M	$85.7M	$151.6M	$152.1M	$549.4M
EPS (Basic) USD/shares	-42.7%	+5.9%	—	—	$0.59	$0.28	-$6.50	-$0.60	$1.49	$2.11	$0.21	$1.60	$1.80	$2.35
EPS (Diluted) USD/shares	-41.1%	+7.0%	—	$1.50 – $1.55*	$0.58	$0.28^G	-$6.50	-$0.60	$1.37	$1.92	$0.20	$1.60	$1.80	$2.35
Shares Outstanding (Basic Avg) shares	+1.0%	+1.0%	—	—	—	168M	172.2M	166.9M	162.9M	161.2M	159.6M	136.2M	127.9M	127.9M
Shares Outstanding (Diluted Avg) shares	-1.6%	+0.6%	—	—	—	169.2M	172.2M	166.9M	177.6M	177.6M	164.1M	136.4M	127.9M	127.9M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Current operating lease liabilities	2026-07-03	USD 38,500,000	10-Q filed 2026-08-05
Noncurrent debt carrying amount	2026-07-03	USD 1,436,300,000	10-Q filed 2026-08-05
Noncurrent operating lease liabilities	2026-07-03	USD 113,200,000	10-Q filed 2026-08-05

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

1.39×

Peer median 3.22×

EV/EBIT

14.48×

Peer median 33.88×

P/E (TTM)

39.98×

Peer median 31.27×

Peer medians compare against the 25 similar-size Medical Instruments & Supplies companies (of 51 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Specialty Products and Technologies	$1,752,800,000	$1,616,400,000	$1,642,400,000	$1,598,600,000	$1,507,800,000	$1,117,300,000	$1,342,700,000	$1,369,800,000
Equipment and Consumables	$966,700,000	$894,200,000	$924,100,000	$970,500,000	$1,001,100,000	$811,800,000	$942,100,000	$1,474,700,000

By Geography (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
North America	$1,395,200,000	$1,305,300,000	—	—	—	—	—	—
Western Europe	$615,300,000	$546,000,000	—	—	—	—	—	—
High Growth Markets	$586,200,000	$539,000,000	—	—	—	—	—	—
Other Developed Markets	$122,800,000	$120,300,000	—	—	—	—	—	—
China	—	—	$205,700,000	$222,200,000	$236,700,000	$198,200,000	$189,000,000	$187,900,000
Germany	—	—	—	—	—	—	—	$164,700,000
United States	—	—	$1,209,400,000	$1,261,900,000	$1,223,400,000	$960,100,000	$1,098,800,000	$1,240,500,000
All Other Countries	—	—	$1,151,400,000	$1,085,000,000	$1,048,800,000	$770,800,000	$997,000,000	$1,251,400,000

By Product & Service (USD)

Component	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Consumables	$2,147,500,000	$2,067,900,000	$1,590,700,000	$1,866,100,000	$1,914,800,000	$1,864,700,000
Equipment Sales	$421,600,000	$441,000,000	$338,400,000	$418,700,000	$929,700,000	$946,200,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Specialty Products and Technologies	$191,200,000	$89,900,000	$232,100,000	$268,600,000	$272,300,000	$65,800,000	$218,300,000	$241,300,000
Equipment and Consumables	$158,000,000	$152,300,000	$156,300,000	$172,400,000	$153,800,000	$53,600,000	$73,400,000	$120,500,000

Operating Margin by Segment (%)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Specialty Products and Technologies	10.9%	5.6%	14.1%	16.8%	18.1%	5.9%	16.3%	17.6%
Equipment and Consumables	16.3%	17%	16.9%	17.8%	15.4%	6.6%	7.8%	8.2%

Key facts CIK 1757073 CUSIP 29415F104 13F (30d) 49 filings 49 filers Visit website Investor relations